Ollin Biosciences reported raising $330 Million in an initial SEC Form D filing, from an offering of $330 Million
Round Type
Series B
Investors
Description
Ollin Biosciences, focused on eye diseases, raised $330 million in a Series B financing round. The funds will be used for pivotal research of OLN324, aimed at combating vision loss. Key investors included Arch Venture Partners, TCGX, and others. This financing will help Ollin progress its lead experimental medicine into Phase 3 testing.
Quick answer
Ollin Biosciences raised $330 Million in a Series B round, dated May 14, 2026. Investors: Monograph Capital, Accounts Advised By T. Rowe Price, Blackstone Multi Asset Investing, RA Capital Management, ARCH Venture Partners and Tcgx.
- How much did Ollin Biosciences raise?
- Ollin Biosciences raised $330 Million in a Series B round on May 14, 2026.
- Who invested in Ollin Biosciences?
- Monograph Capital, Accounts Advised By T. Rowe Price, Blackstone Multi Asset Investing, RA Capital Management, ARCH Venture Partners and Tcgx are named as investors in this round.
- What does Ollin Biosciences do?
- Ollin Biosciences is a startup focused on developing treatments for eye diseases.
- Who are the decision-makers at Ollin Biosciences?
- Fundz holds 1 contact at Ollin Biosciences, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Ollin Biosciences that raised within 45 days of this round, from Fundz verified event records.
- Thalia Therapeutics plc raised $3.5M (Seed) on June 26, 2026.
- FibroBiologics raised $3M (Post-IPO Equity) on June 25, 2026.
- Serapha Bio raised $230M (Series A) on June 25, 2026.
- Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
- Oblenio Bio raised $62M (Series B) on June 25, 2026.
- Osanni Bio raised $190M (Series B) on June 23, 2026.
Who to call at Ollin Biosciences, and when
A new round usually means Ollin Biosciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ollin Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ollin Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ollin Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ollin Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansOllin Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.